Showing results (421-430 of 1,784) with videos related to

Sort By:
Pageof 179
Dermatology and Therapy|May 19, 2026
The Role of Inflammatory Biomarkers in Disease Severity and Treatment Response across Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa-A Narrative ReviewJulia Alicja Lewandowska, Agnieszka Owczarczyk-Saczonek
Dermatology and Therapy|May 2, 2026
A Narrative Review: Do Systemic Drugs Used in the Treatment of Psoriatic Disease Affect Alzheimer's Disease?Jin-Hui Chen, Tsen-Fang Tsai
Dermatology and Therapy|May 24, 2026
Efficacy of Upadacitinib in Patients with Atopic Dermatitis of the Head and Neck RegionKilian Eyerich, Pedro Mendes-Bastos, Gregor Holzer, et al.
Dermatology and Therapy|April 29, 2026
A Prebiotic and Panthenol-Containing Repair Balm Improves Tolerability of Topical 5-Fluorouracil Field Therapy for Actinic Keratoses: A Randomised Controlled TrialAnne Tseng, Regina Yu, Susan Brown, et al.
Dermatology and Therapy|May 27, 2026
Impact of Biologic Treatment Duration on Drug-Free Remission in Moderate-to-Severe Psoriasis: A Retrospective Cohort StudyChe-Chia Hsu, Yu-Huei Huang, Tsen-Fang Tsai
Dermatology and Therapy|May 26, 2026
Topical Timolol Beyond Infancy: A Retrospective Study of Its Use in Persistent Infantile HemangiomasOlga Bogomolets, Sofiia Bogomolets-Sheremetieva
Dermatology and Therapy|May 14, 2026
Summary of Research: Apremilast Improves Skin Outcomes in Pediatric Plaque Psoriasis of Shorter Disease Duration: 52-Week Results from the SPROUT Phase 3 TrialRichard G Langley, Lisa Arkin, Loretta Fiorillo, et al.
Dermatology and Therapy|May 15, 2026
Machine-Learning-Based Prediction of Long-Term Efficacy of Nemolizumab: Post Hoc Analysis of Pooled Data from Two Phase III Clinical TrialsMakoto Kawashima, Tomoya Maeda, Kotaro Iwasaki, et al.
Dermatology and Therapy|June 26, 2021
Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological DrugsPaolo Gisondi, Francesco Bellinato, Stefano Piaserico, et al.
Dermatology and Therapy|July 21, 2026
Longitudinal Performance of the Psoriasis Epidemiology Screening Tool (PEST) in Canada and Latin America: Results from the Prospective, Observational, 5-Year PURE RegistryJennifer Beecker, Lorne Albrecht, Ignacio Dei-Cas, et al.
Pageof 179